Fact:
These products are reviewed by the FDA for quality, safety, and effectiveness.
Myth:
Compounded GLP-1s are just cheaper versions of the same thing
Fact:
Compounded GLP-1 medicines are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before they are marketed. They may be appropriate in limited circumstances when a patient’s medical needs cannot be met by an available FDA-approved drug, but they can carry additional risks related to quality and dosing.
As GLP-1 medications like semaglutide and tirzepatide have become more widely used, consumers have also encountered counterfeit, illegally marketed, and other unapproved products. Counterfeit or illegal products may be mislabeled, contain incorrect doses or ingredients, or come from unverified sellers. Compounded GLP-1 medicines are different: they are not FDA-approved, but they may be legally prepared under specific circumstances for an individual patient whose medical needs cannot be met by an available FDA-approved drug.
Don’t fall for fakes. Follow the facts.
Before you buy, verify!
Quality You Can Trust vs. Gambles You Can't!
Your Health Deserves the Real Thing!
Don’t fall for fakes. Follow the facts.
Before you buy, verify!
Quality You Can Trust vs. Gambles You Can't!
Your Health Deserves the Real Thing!
These products are reviewed by the FDA for quality, safety, and effectiveness. Each batch is manufactured under strict standards, with consistent ingredients and dosing. Your prescription is filled by a licensed pharmacy.
Compounding is intended for an individual patient when an approved product is unavailable or a patient needs a customized form (e.g., allergy, different dosage form). Compounded versions are not FDA‑approved and may vary in strength, purity, and stability.
Counterfeit or illegally marketed weight-loss drugs may contain the wrong ingredient, an incorrect amount of medicine, or harmful contaminants. Products from unverified sources may also have misleading labels, unsafe storage conditions, or unclear dosing instructions. Use prescription GLP-1 medicines only under the care of a licensed health care professional and obtain them from a licensed pharmacy.
FDA-approved GLP-1 medicines have been reviewed by the FDA for safety, effectiveness, quality, and manufacturing standards. Compounded GLP-1 medicines are not FDA-approved and are not reviewed by the FDA before they are marketed for safety, effectiveness, or quality. Compounded medicines may be appropriate for certain patients with a specific medical need that cannot be met by an available FDA-approved drug.
Ask why a compounded medicine is being recommended and whether an FDA-approved option can meet your medical needs. Compounded drugs can serve an important medical need for some patients, but they are not FDA-approved. If a compounded GLP-1 is prescribed, make sure it is filled by a properly licensed pharmacy and ask about the ingredients, dose, storage, and how to use it safely.
Avoid buying prescription GLP-1 medicines from social media sellers or websites that cannot be verified as legitimate pharmacies. Products from unlicensed or unverified sellers may be counterfeit, contaminated, improperly stored, or contain the wrong ingredients or dose. Get a prescription from a licensed health care professional and fill it through a state-licensed pharmacy.
Compounded GLP-1 medicines are not FDA-approved and may only be prepared under specific legal conditions. In April 2026, FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List after finding no clinical need for outsourcing facilities to compound these drugs from bulk substances.
Bulk API from unverified foreign suppliers can be detained at the border; products labeled “research use only/not for human use” are not appropriate for patients.
Salt forms such as semaglutide sodium or semaglutide acetate are different active ingredients from the semaglutide used in FDA-approved medicines. FDA has said it is not aware of a lawful basis for using these salt forms in compounded drugs and has raised concerns about their safety and effectiveness.